• Medical Device Tax

    BioUtah strongly urges Congress to take timely action to repeal, or at a minimum, further suspend the 2.3% excise tax on medical devices sales that became effective January 1, 2018. Repealing the medical device tax will provide medical technology innovators with the long-term certainty necessary to support future job growth and sustainable, cutting-edge R&D that will ultimately lead to the next generation of breakthroughs in patient care and treatment. 

    Here you will find the latest news and information about efforts to repeal the Medical Device Tax, including efforts of both BioUtah and Utah's congressional delegation.

  • Presented by